Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Biomedical Materials Research
|
August 1, 1994
Evaluation of a series of tyrosine-derived polycarbonates as degradable biomaterials
S I Ertel, J Kohn
Expert Opinion on Investigational Drugs
|
May 1, 1997
Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blocker
S I Ertel, J P Clozel
Trends in Pharmacological Sciences
|
February 1, 1997
Low-voltage-activated T-type Ca2+ channels
S I Ertel, E A Ertel
Journal of Biomedical Materials Research
|
December 1, 1990
Radiofrequency plasma deposition of oxygen-containing films on polystyrene and poly(ethylene terephthalate) substrates improves endothelial cell growth
S I Ertel, B D Ratner, T A Horbett
Proceedings of the Association of American Physicians
|
October 16, 1999
Voltage-gated T-type Ca2+ channels and heart failure
J P Clozel, E A Ertel, S I Ertel
Journal of Molecular Medicine (Berlin, Germany)
|
June 3, 1999
Endothelin antagonism with bosentan: a review of potential applications
S Roux, V Breu, S I Ertel, et al.
Cardiovascular Drugs and Therapy
|
March 26, 1998
T-type Ca2+ channels and pharmacological blockade: potential pathophysiological relevance
S I Ertel, E A Ertel, J P Clozel
Expert Opinion on Investigational Drugs
|
July 5, 2005
The pharmacology of bosentan
V Breu, S I Ertel, S Roux, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
March 3, 1998
Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker
J P Clozel, E A Ertel, S I Ertel
Journal of Biomedical Materials Research
|
November 1, 1995
Evaluation of poly(DTH carbonate), a tyrosine-derived degradable polymer, for orthopedic applications
S I Ertel, J Kohn, M C Zimmerman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Biomedical Materials Research
|
August 1, 1994
Evaluation of a series of tyrosine-derived polycarbonates as degradable biomaterials
S I Ertel, J Kohn
Expert Opinion on Investigational Drugs
|
May 1, 1997
Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blocker
S I Ertel, J P Clozel
Trends in Pharmacological Sciences
|
February 1, 1997
Low-voltage-activated T-type Ca2+ channels
S I Ertel, E A Ertel
Journal of Biomedical Materials Research
|
December 1, 1990
Radiofrequency plasma deposition of oxygen-containing films on polystyrene and poly(ethylene terephthalate) substrates improves endothelial cell growth
S I Ertel, B D Ratner, T A Horbett
Proceedings of the Association of American Physicians
|
October 16, 1999
Voltage-gated T-type Ca2+ channels and heart failure
J P Clozel, E A Ertel, S I Ertel
Journal of Molecular Medicine (Berlin, Germany)
|
June 3, 1999
Endothelin antagonism with bosentan: a review of potential applications
S Roux, V Breu, S I Ertel, et al.
Cardiovascular Drugs and Therapy
|
March 26, 1998
T-type Ca2+ channels and pharmacological blockade: potential pathophysiological relevance
S I Ertel, E A Ertel, J P Clozel
Expert Opinion on Investigational Drugs
|
July 5, 2005
The pharmacology of bosentan
V Breu, S I Ertel, S Roux, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
March 3, 1998
Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker
J P Clozel, E A Ertel, S I Ertel
Journal of Biomedical Materials Research
|
November 1, 1995
Evaluation of poly(DTH carbonate), a tyrosine-derived degradable polymer, for orthopedic applications
S I Ertel, J Kohn, M C Zimmerman, et al.
Page
of 2